论文部分内容阅读
一项对于美国食品药品管理局不良事件报告系统数据库的研究发现,联合使用降胆固醇药物普伐他丁和抗抑郁药帕罗西汀会显著增加平均血糖水平。美国学者研究发现,接受帕罗西汀伴随普伐他丁治疗的门诊患者与接受其他他汀类-选择性羟色胺再摄取抑制剂(SSRI)伴随药物治疗的患者之间,平均血糖水平无显著差异。论文2014年6月在线发表于《药物治疗学年鉴》(Ann Pharmacother)。(摘自《医学论坛网》)
A study of the FDA’s Adverse Event Reporting System database found that the combination of the cholesterol lowering drug pravastatin and the antidepressant paroxetine significantly increased mean blood glucose levels. The American scholar found no significant difference in average blood glucose levels between outpatients who received paroxetine and pravastatin and those who received other statin-serotonin reuptake inhibitors (SSRIs) with medication. The paper was published online in June 2014 at Ann Pharmacother. (From “Medical Forum Network”)